Name: Dr. Khajeelak Chiablaem Office address: Research Laboratory of Biochemistry, Chulabhorn Research Institute, 54 Kamphaeng Phet 6 Talat Bang Khen, Lak Si, Bangkok 10210, Thailand Tel: +662-5538555 (ext. 3242) E-mail:
[email protected] Positions: Research Scientist I, Research Laboratory of Biochemistry, Chulabhorn Research Institute Research Interests 1. Cancer bioinformatics 2. Cancer invasion and metastasis 3. Cancer and alternative medicine Education and Degrees: • B.Sc. (Biology), Chiang Mai University, Thailand • M.Sc. (Technoprenership and Innovation Management), Chulalongkorn University, Thailand • Ph.D. (Translational Medicine), Mahidol University, Thailand ORCID ID: http://orcid.org/0000-0002-9139-4695 Publications 1. Chiablaem K, Jinawath A, Nuanpirom J, Arora JK, Nasaree S, Thanomchard T, Singhto N, Chittavanich P, Suktitipat B, Charoensawan V, Chairoungdua A, Jinn-Chyuan Sheu J, Kiyotani K, Svasti J, Nakamura Y, Jinawath N. Identification of RNF213 as a Potential Suppressor of Local Invasion in Intrahepatic Cholangiocarcinoma. Lab Invest. 2024 Jul;104(7):102074. doi: 10.1016/j.labinv.2024.102074. 2. Shiao MS, Chiablaem K, Charoensawan V, Ngamphaiboon N, Jinawath N. Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type. Front Genet. 2018 Aug 15;9:309. doi: 10.3389/fgene.2018.00309. 3. Samutprasert P, Chiablaem K, Teeraseranee C, Phaiyarin P, Pukfukdee P, Pienpinijtham P, Svasti J, Palaga T, Lirdprapamongkol K, Wanichwecharungruang S. Epigallocatechin gallate-zinc oxide co-crystalline nanoparticles as an anticancer drug that is non-toxic to normal cells. RSC Adv. 2018 Feb 15;8(14):7369-7376. doi: 10.1039/c7ra10997k. 4. Kuljittichanok D, Diskul-Na-Ayudthaya...